Differential Sensitivity of Glioma-versus Lung Cancer-Specific EGFR Mutations to EGFR Kinase Inhibitors Article

Vivanco, Igor, Robins, H Ian, Rohle, Daniel et al. (2012). Differential Sensitivity of Glioma-versus Lung Cancer-Specific EGFR Mutations to EGFR Kinase Inhibitors . CANCER DISCOVERY, 2(5), 458-471. 10.1158/2159-8290.CD-11-0284

Open Access

cited authors

  • Vivanco, Igor; Robins, H Ian; Rohle, Daniel; Campos, Carl; Grommes, Christian; Nghiemphu, Phioanh Leia; Kubek, Sara; Oldrini, Barbara; Chheda, Milan G; Yannuzzi, Nicolas; Tao, Hui; Zhu, Shaojun; Iwanami, Akio; Kuga, Daisuke; Dang, Julie; Pedraza, Alicia; Brennan, Cameron W; Heguy, Adriana; Liau, Linda M; Lieberman, Frank; Yung, WK Alfred; Gilbert, Mark R; Reardon, David A; Drappatz, Jan; Wen, Patrick Y; Lamborn, Kathleen R; Chang, Susan M; Prados, Michael D; Fine, Howard A; Horvath, Steve; Wu, Nian; Lassman, Andrew B; DeAngelis, Lisa M; Yong, William H; Kuhn, John G; Mischel, Paul S; Mehta, Minesh P; Cloughesy, Timothy F; Mellinghoff, Ingo K

sustainable development goals

authors

publication date

  • May 1, 2012

published in

keywords

  • 3T3 CELLS
  • EPIDERMAL-GROWTH-FACTOR
  • FACTOR RECEPTOR INHIBITORS
  • GEFITINIB
  • GLIOBLASTOMA
  • LAPATINIB
  • Life Sciences & Biomedicine
  • MALIGNANT GLIOMAS
  • Oncology
  • Science & Technology
  • THERAPY
  • TUMOR-CELLS
  • TYROSINE KINASE

Digital Object Identifier (DOI)

publisher

  • AMER ASSOC CANCER RESEARCH

start page

  • 458

end page

  • 471

volume

  • 2

issue

  • 5